SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-036668
Filing Date
2024-04-26
Accepted
2024-04-26 16:28:40
Documents
19
Period of Report
2024-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204729-8k_inmune.htm   iXBRL 8-K 32163
2 FORM OF WARRANT ea020472901ex4-1_inmune.htm EX-4.1 95020
3 OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP ea020472901ex5-1_inmune.htm EX-5.1 14936
4 FORM OF SECURITIES PURCHASE AGREEMENT ea020472901ex10-1_inmune.htm EX-10.1 224307
5 FORM OF PLACEMENT AGENCY AGREEMENT ea020472901ex10-2_inmune.htm EX-10.2 59005
6 PRESS RELEASE, DATED APRIL 25, 2024 ea020472901ex99-1_inmune.htm EX-99.1 11868
10 GRAPHIC ex5-1_001.jpg GRAPHIC 5609
  Complete submission text file 0001213900-24-036668.txt   727696

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inmb-20240424.xsd EX-101.SCH 3018
8 XBRL LABEL FILE inmb-20240424_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE inmb-20240424_pre.xml EX-101.PRE 22361
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0204729-8k_inmune_htm.xml XML 3799
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 24884289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)